Relationship between kinetics of the molecular response and disease recurrence
| PCR negativization in the bone marrow following rituximab . | Event rate (%) . | χ2 . | Log rank . |
|---|---|---|---|
| Rapid and sustained (at wk +12, +28, and +44) | 4/33 (12) | — | — |
| Late but sustained (at wk +28 and +44) | 2/12 (17) | 0.69 | 0.84 |
| Transient (at wk +12 and +28 but not +44) | 8/17 (47) | 0.006 | 0.003 |
| Absent | 7/14 (50) | 0.005 | 0.01 |
| PCR negativization in the bone marrow following rituximab . | Event rate (%) . | χ2 . | Log rank . |
|---|---|---|---|
| Rapid and sustained (at wk +12, +28, and +44) | 4/33 (12) | — | — |
| Late but sustained (at wk +28 and +44) | 2/12 (17) | 0.69 | 0.84 |
| Transient (at wk +12 and +28 but not +44) | 8/17 (47) | 0.006 | 0.003 |
| Absent | 7/14 (50) | 0.005 | 0.01 |